Provided by Tiger Trade Technology Pte. Ltd.

Verrica Pharmaceuticals Inc.

5.49
+0.20003.78%
Post-market: 5.490.00000.00%16:10 EDT
Volume:129.62K
Turnover:714.05K
Market Cap:94.31M
PE:-3.27
High:5.60
Open:5.31
Low:4.99
Close:5.29
52wk High:9.82
52wk Low:3.28
Shares:17.18M
Float Shares:6.78M
Volume Ratio:1.79
T/O Rate:1.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6800
EPS(LYR):-14.7812
ROE:-240.35%
ROA:-14.74%
PB:3.81
PE(LYR):-0.37

Loading ...

Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 21, 2025

Major Issues Report

Form 8-K - Current report
Jan 30, 2025

Major Issues Report

Form 8-K - Current report
Dec 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Dec 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 09, 2024

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Major Issues Report

Form 8-K - Current report
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Sep 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 27, 2024

Major Issues Report

Form 8-K - Current report
Aug 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities